Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.92	60.61	82.94
Graham Fair Price	27.19	18.72	14.72
PEG	-83.53	0.45	-2.76
Price/Book	-9.68	4.97	5.50
Price/Cash Flow	-40.82	93.99	158.83
Prices/Earnings	-35.16	22.36	34.49
Price/Sales	-2.36	13.55	13.88
Price/FCF	-40.82	93.99	158.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	2.49	0.46	0.45
Operating Margin	43.46	0.20	0.14
ROA	48.28	0.03	0.02
ROE	0.04	0.06	39.28
ROIC	0.03	0.04	42.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	< 0.005	28348.86
Dividends QOQ	< 0.005	0.05	2353.87
EBIT QOQ	-0.16	0.41	165.07
EPS QOQ	-0.12	0.49	293.65
FCF QOQ	-0.41	0.62	50.74
Revenue QOQ	0.05	-0.02	-67.36
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	65.19	65.64	0.70
Days Sales Outstanding (DSO)	31.03	32.65	5.21
Inventory Turnover	1.38	1.37	-0.69
Debt/Capitalization	0.38	0.35	-8.95
Quick Ratio	0.61	0.78	26.89
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	15.54	16.75	7.77
Cash	1.39	1.43	2.86
Capex	-0.41	-0.19	54.01
Free Cash Flow	0.54	0.89	64.48
Revenue	6.16	6.14	-0.31
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.08	1.33	23.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.35	5.06	-31.09
Naive Interpretation	Member

06 - Financial Health · Weak

Rating